Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Feigenbaum

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Progress in Neurobiology|January 1, 1984
Normal and abnormal determinants of dopamine receptor ontogeny in the central nervous systemJ J Feigenbaum, J Yanai
Progress in Medicinal Chemistry|January 1, 1987
Towards cannabinoid drugsR Mechoulam, J J Feigenbaum
Neuroscience Letters|July 5, 1996
Lack of effect of gamma-hydroxybutyrate on mu, delta and kappa opioid receptor bindingJ J Feigenbaum, R Simantov
Neuropharmacology|August 1, 1985
Implications of dopamine agonist-induced hypothermia following increased density of dopamine receptors in the mouseJ J Feigenbaum, J Yanai
Neuropsychobiology|January 1, 1983
Evidence for the involvement of central dopaminergic receptors in the acute and chronic effects induced by barbituratesJ J Feigenbaum, J Yanai
Neuroscience Letters|March 7, 1997
Naloxone reverses the inhibitory effect of gamma-hydroxybutyrate on central DA release in vivo in awake animals: a microdialysis studyJ J Feigenbaum, S G Howard
Biochemical Pharmacology|January 10, 1997
Effect of gamma-hydroxybutyrate on central dopamine release in vivo. A microdialysis study in awake and anesthetized animalsS G Howard, J J Feigenbaum
Neuroscience Letters|October 25, 1996
Naloxone reverses the inhibitory effect of gamma-hydroxybutyrate on central DA release in vivo in awake animals: a microdialysis studyJ J Feigenbaum, S G Howard
Progress in Neurobiology|September 1, 1996
Gamma hydroxybutyrate is not a GABA agonistJ J Feigenbaum, S G Howard
The International Journal of Neuroscience|November 1, 1996
Does gamma-hydroxybutyrate inhibit or stimulate central DA release?J J Feigenbaum, S G Howard
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Progress in Neurobiology|January 1, 1984
Normal and abnormal determinants of dopamine receptor ontogeny in the central nervous systemJ J Feigenbaum, J Yanai
Progress in Medicinal Chemistry|January 1, 1987
Towards cannabinoid drugsR Mechoulam, J J Feigenbaum
Neuroscience Letters|July 5, 1996
Lack of effect of gamma-hydroxybutyrate on mu, delta and kappa opioid receptor bindingJ J Feigenbaum, R Simantov
Neuropharmacology|August 1, 1985
Implications of dopamine agonist-induced hypothermia following increased density of dopamine receptors in the mouseJ J Feigenbaum, J Yanai
Neuropsychobiology|January 1, 1983
Evidence for the involvement of central dopaminergic receptors in the acute and chronic effects induced by barbituratesJ J Feigenbaum, J Yanai
Neuroscience Letters|March 7, 1997
Naloxone reverses the inhibitory effect of gamma-hydroxybutyrate on central DA release in vivo in awake animals: a microdialysis studyJ J Feigenbaum, S G Howard
Biochemical Pharmacology|January 10, 1997
Effect of gamma-hydroxybutyrate on central dopamine release in vivo. A microdialysis study in awake and anesthetized animalsS G Howard, J J Feigenbaum
Neuroscience Letters|October 25, 1996
Naloxone reverses the inhibitory effect of gamma-hydroxybutyrate on central DA release in vivo in awake animals: a microdialysis studyJ J Feigenbaum, S G Howard
Progress in Neurobiology|September 1, 1996
Gamma hydroxybutyrate is not a GABA agonistJ J Feigenbaum, S G Howard
The International Journal of Neuroscience|November 1, 1996
Does gamma-hydroxybutyrate inhibit or stimulate central DA release?J J Feigenbaum, S G Howard
Pageof 5